QR код

Lanadelumab in a kidney transplant patient with hereditary angioedema due to C1-inhibitor deficiency and high cardiovascular risk - a case report

IntroductionCardiovascular pathologies represent the first cause of death in uremic patients and are among the leading causes of mortality in patients with hereditary angioedema due to C1-inhibitor deficiency (HAE-C1INH). Before 2020, the most common treatment for long-term prophylaxis in HAE-C1INH...

Повний опис

Збережено в:
Автори: Antonio Gidaro, Leyla La Cava, Mattia Donadoni, Valentina Popescu Janu, Chiara Cogliati, Antonio Luca Brucato, Andrea Zanichelli, Mauro Cancian, Emanuele Bizzi
Формат: Artigo
Мова:Inglês
Опубліковано: Frontiers Media S.A. 2024-09-01
Серія:Frontiers in Immunology
Предмети:
hereditary angioedema due to C1-inhibitor deficiency (HAE-C1INH)
kidney failure
kidney transplantation
androgens
lanadelumab
Онлайн доступ:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1472390/full
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!

Схожі ресурси